Ditchcarbon
  • Contact
  1. Organizations
  2. Axogen
Public Profile
Business Services
US
updated a month ago

Axogen Sustainability Profile

Company website

Axogen, Inc., headquartered in the United States, is a leading innovator in the field of regenerative medicine, specialising in peripheral nerve repair. Founded in 2002, the company has made significant strides in advancing surgical solutions for nerve injuries, with a focus on providing high-quality products that enhance patient outcomes. With a robust portfolio that includes Axoguard® Nerve Connector and Avance® Nerve Graft, Axogen stands out for its commitment to utilising human tissue for nerve repair, setting it apart from traditional synthetic alternatives. The company has established a strong market position, recognised for its pioneering contributions to nerve regeneration and repair. Operating primarily in North America, Axogen continues to expand its influence in the medical device industry, driven by a mission to restore function and improve the quality of life for patients suffering from nerve damage.

DitchCarbon Score

How does Axogen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Axogen's score of 27 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.

51%

Let us know if this data was useful to you

Axogen's reported carbon emissions

In 2022, Axogen, headquartered in the US, reported total carbon emissions of approximately 1,630,000 kg CO2e. This total comprises 526,000 kg CO2e from Scope 1 emissions and 1,104,000 kg CO2e from Scope 2 emissions. Notably, Axogen has not disclosed any Scope 3 emissions data. Currently, Axogen does not have any publicly stated reduction targets or commitments, including those aligned with the Science Based Targets initiative (SBTi). The absence of specific reduction initiatives indicates a potential area for future development in their climate strategy. As part of their corporate responsibility, Axogen is expected to enhance transparency and set measurable targets to address their carbon footprint effectively.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2022
Scope 1
526,000
Scope 2
1,104,000
Scope 3
-

How Carbon Intensive is Axogen's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Axogen's primary industry is Business Services, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Axogen's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Axogen is in US, which has a low grid carbon intensity relative to other regions.

Axogen's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Axogen has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Axogen's Emissions with Industry Peers

Integra lifesciences

US
•
Health and social work services (85)
Updated about 1 month ago

Athersys, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

C. R. Bard, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 months ago

MiMedx Group, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Baxter

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 8 days ago

Derma Sciences, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy